This study to see how the new medicine IcoSema controls blood sugar levels in people with Type 2 diabetes. IcoSema is a combination of insulin icodec and semaglutide taken in a single injection once a week. When you have type 2 diabetes your blood sugar level is not well controlled, and insulin treatment can be helpful.
If you qualify, you may receive study-related care and study medication or an approved medication at no charge. You may also receive compensation for travel expenses.
Participant Eligibility Criteria ( To take part in the study )